1. 3D Printed porous polyamide macrocapsule combined with alginate microcapsules for safer cell-based therapies
- Author
-
Rosa Villa, Xavi Illa, Albert Espona-Noguera, Laura Saenz del Burgo, Rosa Maria Hernandez, Jesús Ciriza, Gorka Orive, José Luis Pedraz, Mar Álvarez, E. Cabruja, and Universitat Politècnica de Catalunya. Departament de Ciència i Enginyeria de Materials
- Subjects
Vascular Endothelial Growth Factor A ,0301 basic medicine ,Cell ,Cell- and Tissue-Based Therapy ,mesenchymal stem-cells ,lcsh:Medicine ,02 engineering and technology ,law.invention ,Mice ,chemistry.chemical_compound ,law ,Cricetinae ,lcsh:Science ,Three-dimensional printing ,Multidisciplinary ,Tissue Scaffolds ,myoblasts ,differentiation ,Cells, Immobilized ,021001 nanoscience & nanotechnology ,VEGF ,Vascular endothelial growth factor ,medicine.anatomical_structure ,Enginyeria de teixits ,Materials biomèdics ,Printing, Three-Dimensional ,Polyamide ,delivery ,0210 nano-technology ,Porosity ,Impressió 3D ,C2C12 ,pancreatic-islets ,Alginates ,Cell Survival ,Drug Compounding ,Capsules ,Enginyeria dels materials [Àrees temàtiques de la UPC] ,Article ,03 medical and health sciences ,vascularization ,medicine ,Animals ,Tissue engineering ,Erythropoietin ,hypoxia ,Pancreatic islets ,Mesenchymal stem cell ,lcsh:R ,Fibroblasts ,Transplantation ,Nylons ,Selective laser sintering ,030104 developmental biology ,chemistry ,lcsh:Q ,Biomedical materials ,Biomedical engineering ,endothelial growth-factor ,transplantation - Abstract
Cell microencapsulation is an attractive strategy for cell-based therapies that allows the implantation of genetically engineered cells and the continuous delivery of de novo produced therapeutic products. However, the establishment of a way to retrieve the implanted encapsulated cells in case the treatment needs to be halted or when cells need to be renewed is still a big challenge. The combination of micro and macroencapsulation approaches could provide the requirements to achieve a proper immunoisolation, while maintaining the cells localized into the body. We present the development and characterization of a porous implantable macrocapsule device for the loading of microencapsulated cells. The device was fabricated in polyamide by selective laser sintering (SLS), with controlled porosity defined by the design and the sintering conditions. Two types of microencapsulated cells were tested in order to evaluate the suitability of this device; erythropoietin (EPO) producing C2C12 myoblasts and Vascular Endothelial Growth Factor (VEGF) producing BHK fibroblasts. Results showed that, even if the metabolic activity of these cells decreased over time, the levels of therapeutic protein that were produced and, importantly, released to the media were stable. This work was done under the BIOPAN project (CIBER-BBN). Authors wish to thank the intellectual and technical assistance from the ICTS "NANBIOSIS", more specifically by the Drug Formulation Unit (U10) and the Micro-Nano Technology Unit (U8) of the CIBER in Bioengineering, Biomaterials & Nanomedicine (CIBERBBN). Also, they thank the support to research on cell microencapsulation from the University of the Basque Country UPV/EHU (EHUA 16/06) and the Basque Country Government (Grupos Consolidados, No ref: IT907-16). The authors acknowledge the financial support from the Ministerio de Economia y Competitividad (MINECO) (Spain) through Ramon y Cajal program (RYC-2013-14479). This work has made use of the Spanish ICTS Network MICRONANOFABS partially supported by MINECO.
- Published
- 2018